Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Baricitinib, (OBO) ATC L04AA37 für die Zeit 01.02.2025 - 31.01.2027
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Baricitinib, (OBO) ATC L04AA37 für die Zeit 01.02.2025…”. Bids close on 4 December 2026.
The work
Conclusion of a non-exclusive discount agreement for the active substance Baricitinib (ATC L04AA37) for the period 01.02.2025 - 31.01.2027.
- Agreement is a framework contract under § 130a Abs. 8 SGB V
- Contract ends automatically with the entry into force of an exclusive contract
Key facts
- Contract period
- 01.02.2025 - 31.01.2027
- Evaluation
- Not a formal procurement procedure; based on meeting submission requirements.
What it takes to qualify
Worth a closer look
- The document states this is not a formal procurement procedure and does not fall under cartel procurement law, but uses the form for open procedures for technical reasons.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- AngebotsschreibenMust include declaration that no exclusion criteria under §§ 123 and 124 GWB apply.
- Anerkennung der vertraglichen Maßgaben der DAK-GesundheitSubmission of the signed contract with name or company stamp.
- Anlage 1 zum VertragTo be filled out and submitted.
- Anlage 2 zum VertragExcel file listing the medicinal products for the contract.